FDA 483 - Societal CDMO Gainesville, LLC - February 27, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Societal CDMO Gainesville, LLC, a manufacturer of prescription solid oral drugs, was inspected by the FDA and received a Form 483. The inspection revealed significant deficiencies in production and process controls, including inadequate written procedures and issues with blend uniformity. Additionally, the firm failed to thoroughly review unexplained discrepancies and exhibited inadequate controls over computer systems, including shared access and excessive operator privileges.
ID · 8aca8323-ae3b-48fd-a6e1-82cf4597f762